http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002330753-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_783d2d8620996b78524500eb9322fdd6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
| filingDate | 2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5edca9aa5d515fa1c30b76c01fd6f2 |
| publicationDate | 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002330753-A |
| titleOfInvention | Regulation of the immune system |
| abstract | PROBLEM TO BE SOLVED: To provide a particularly advantageous improvement in host resistance to infection by an agent which enhances the defense regulation of the immune system without causing the undesirable side effects observed with DHEA administration. Second, the defense modulation of the immune system can be effected with the use of low doses of chemotherapeutic agents, providing a fast-acting response with broad protection. The present invention provides an androstenediol (A) Administration of ED) and Androstentriol (AET) provides improved methods for modulating the immune response, ameliorating stress effects, and avoiding the undesired effects of chemotherapy or radiation exposure. Improved methods of immune response regulation can be used in the treatment of infectious diseases and immune diseases such as diabetes and chronic fatigue syndrome, both of which are now considered immune response related syndromes. |
| priorityDate | 2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.